Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.340 | 0.0100 | ||||
REV | 60.000K | 0 | -60.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ORTX | Orchard Therapeutics | 6.73 | -0.25 | -3.58% | 832.5M |
You can purchase shares of Orchard Therapeutics (NASDAQ: ORTX) through any online brokerage.
Other companies in Orchard Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Humanigen (NASDAQ:HGEN) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Orchard Therapeutics (NASDAQ: ORTX) was reported by JP Morgan on 2021-03-02. The analyst firm set a price target for 15.00 expecting ORTX to rise to within 12 months (a possible 122.88% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Orchard Therapeutics (NASDAQ: ORTX) is $6.73 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Orchard Therapeutics.
There is no upcoming split for Orchard Therapeutics.